Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin for Prevention of Postoperative Delirium in Cardiac Surgery
NCT05864677Unknown
- Sponsor
- Medical University of Lublin
- Start
- Jan 2023
- Primary completion
- Jun 2024
- Modality
- Native Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of cerebrolysin in postoperative delirium (POD) (2 arms), sponsored by Medical University of Lublin. Primary endpoints: Incidence of delirium assessed by Confusion Assessment Method for ICU (CAM-ICU) at Day 5, Incidence of delirium assessed by Montreal Cognitive Assessment (MoCA) at Day 5 and 1 more. Status: unknown.
02
Drugs
cerebrolysin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05864677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05864677.